Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

NCT03290534 is registered in ClinicalTrials.gov with CivaTech Oncology as lead sponsor.

NCT NCT03290534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03290534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
Lead sponsor
CivaTech Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
March 13, 2019
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer stage i, lung cancer stage ii